The Cheesecake Factory has just reported earnings, and the Street's immediate verdict is a wave of upward target revisions — but with a meaningful split on whether the stock, now trading at $89, has already priced in the good news.
The analyst response this morning was broad and mostly positive in direction, though not uniformly bullish. Oppenheimer's Brian Bittner lifted his target to $101 and held his Outperform rating, while Baird raised its target sharply from $65 to $90 and Stephens moved from $80 to $93 — both maintaining neutral stances. Mizuho also raised its target to $93 but kept Neutral. The notable divergence: Morgan Stanley upgraded from Underweight to Equal-Weight with a $80 target, acknowledging the move but stopping well short of chasing it. Jefferies went the other way entirely, downgrading from Buy to Hold even while lifting its target to $88. UBS, the lone bear, raised its Sell target from $53 to $60 — still 33% below current levels. The consensus sits at Hold with 4 buys, 14 holds, and 1 sell; the mean target at $90.80 is essentially at the market price, which tells you the Street thinks the result validates the run without leaving much further upside on the table.
Short interest remains the stock's most distinctive feature heading out of the print. Around 17.3% of the free float is still sold short — high by casual dining standards and broadly consistent with the elevated readings in place for weeks. The short score has eased from 70 earlier this month to 64.7 as of Tuesday, a modest but directional softening. What's changed more sharply is availability: it has loosened dramatically, jumping to 333% from 222% a week ago, meaning more than three shares are now available in the lending pool for every one currently borrowed. Borrow cost dropped back to 0.60% on Tuesday after briefly touching 1.18% on Monday — a spike that has unwound quickly. Options traders remain only mildly cautious; the put/call ratio at 0.93 is less than one standard deviation above its 20-day mean. None of this suggests a squeeze is building — if anything, the borrow market is signalling that some shorts may have covered into the print.
The broader peer group moved with CAKE this week. DRI gained 7% on the week and HGV added 7.2%, both outpacing CAKE's 2.2% weekly gain — though those moves reflect their own catalysts. BJRI, the closest peer by correlation, added just 1.5%. BROS was the lone decliner in the group, off 2.2%.
Insider activity in recent months has been one-directional. Founder and CEO David Overton sold 104,000 shares in early May at $61 — a $6.3 million transaction — and a cluster of smaller C-suite sales came through April 1st, with the CFO, President, and General Counsel all trimming positions. Those sales occurred 30-35% below today's price, so they carry limited read-through now, but the net 90-day insider position remains a seller of roughly $7.2 million in aggregate value. No purchases are recorded in the window.
The prior two earnings prints offer a muted historical benchmark: CAKE gained 1.7% the day after the May result but gave it back over the following week, and barely moved after the April print before sliding 3.3% over five days. The pattern suggests the stock has tended to fade after initially absorbing results — the question now is whether tonight's print, arriving with the stock 27% higher than where it sat for those prior reactions, changes that dynamic or repeats it.
What to watch next is whether the short base — still 17% of float — begins to cover meaningfully now that results are in, or whether the Wall Street target clustering near $90 gives bears reason to hold their positions against a stock that has already run well ahead of most analyst models.
See the live data behind this article on ORTEX.
Open CAKE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
